Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Journal of Agricultural and Food Chemistry|January 7, 2009
Antimicrobial activity of coffee melanoidins-a study of their metal-chelating propertiesJosé A Rufián-Henares, Silvia P de la CuevaFood Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|August 15, 2009
Assessment of hydroxymethylfurfural intake in the Spanish dietJ A Rufían-Henares, S P de la CuevaActas Dermo-Sifiliograficas|June 24, 2020
Theory and Practice of Compression Therapy for Treating and Preventing Venous UlcersE Conde Montero, N Serra Perrucho, P de la Cueva DobaoPrenatal Diagnosis|April 1, 1996
Early amniocentesis at 10-12 weeks' gestationM Diaz Vega, P De La Cueva, C Leal, et al.The Journal of Dermatological Treatment|August 30, 2016
Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physiciansJ M Carrascosa, P de la Cueva, P Herranz, et al.Actas Dermo-Sifiliograficas|March 11, 2019
A Cost-per-Number Needed to Treat Analysis Assessing the Efficiency of Biologic Drugs in Moderate to Severe Plaque PsoriasisM Núñez, T Huete, P de la Cueva, et al.Actas Dermo-Sifiliograficas|November 4, 2023
Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish DermatologistsE Vilarrasa, R Rivera, N Eiris, et al.Actas Dermo-Sifiliograficas|March 13, 2024
[Translated article] Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish DermatologistsE Vilarrasa, R Rivera, N Eiris, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 26, 2006
Burow's grafts in the facial regionR Cabeza-Martínez, V Leis, M Campos, et al.The British Journal of Dermatology|June 4, 2016
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohortsI García-Doval, M V Hernández, F Vanaclocha, et al.Pageof 10